In summary, although PGM3 deficiency is a multisystemic disorder, hallmark features of recurrent infections, chronic severe neutropenia, and virus-driven malignancies with early adult mortality strongly support early HSCT consideration in these patients. The gene discussed is PGM3; the disease is neutropenia.